Almost three years ago to the day, the Supreme Court shielded the Affordable Care Act (ACA) from a constitutional assault that nearly decapitated President Barack Obama’s signature legislative achievement. In […]
In recent weeks, the threat to South Korea from Middle East Respiratory Syndrome, better known as MERS, has exploded. Over the last 18 months or so, Ebola has hit West […]
To the dismay of political conservatives, Chief Justice John Roberts has now rescued President Obama’s Affordable Care Act (ACA) not once, but twice, from provocative legal challenges. Recall that in […]
Provides identification of potential patient safety issues and actionable insight into clinical trial site performance RESEARCH TRIANGLE PARK, N.C. – June 15, 2015 – Quintiles, the world’s largest biopharmaceutical services […]
Easy-to-use, fingertip access to essential clinical trial insights RESEARCH TRIANGLE PARK, N.C. – June 16, 2015 – Quintiles, the world’s largest biopharmaceutical services company, is extending its award-winning Quintiles […]
The Supreme Court has held that the Patient Protection and Affordable Care Act, sometimes called “Obamacare,” authorized federal health care tax credits for taxpayers living in states with exchanges and taxpayers […]
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. today announced the election of Joseph J. Echevarria to its Board of Directors, effective immediately. Mr. Echevarria also was appointed to the Audit, Regulatory and Compliance […]
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced important next steps in the evolution of the company’s R&D organization, including plans to expand its presence within hubs of scientific excellence […]
Immunovaccine and Incyte to Co-Fund Clinical Trial Combining DPX-Survivac and Epacadostat for Patients with Recurrent Disease HALIFAX, NOVA SCOTIA–(Marketwired – June 25, 2015) – Immunovaccine Inc. (“Immunovaccine” or the “Company”) […]
Data Presented at the International Congress of Parkinson’s Disease and Movement Disorders APL-130277, Sublingual Apomorphine, for On-Demand Treatment of OFF Episodes Associated with Parkinson’s Disease TORONTO, ONTARIO–(Marketwired – June 25, […]
